TA Associates
TA closes global growth fund at $8.5b hard cap
Global growth equity investor TA Associates has reached a first and final close on its latest fund – TA XIII – at the hard cap of $8.5 billion.
TA invests in India fertility business
TA Associates has acquired a significant minority stake in Indira IVF, an India-based provider of infertility services.
TA promotes India head Dhiraj Poddar
Dhiraj Poddar, a director for TA Associates who heads the GP’s India operations, has been promoted to managing director.
India fintech: Corporations act
Stakeholders foresee progress and problems as global strategic investors make their first bets in the Indian fintech space. There is little expectation of replicating the China story
TA invests in India mutual funds business
TA Associates has acquired a minority stake in Prudent Corporate Advisory Services, an India-focused provider of mutual funds and other wealth management products.
India's PE-backed Atria files for IPO
Indian broadband service provider Atria Convergence Technologies has filed for an IPO that will provide partial exits for its PE backers TA Associates and True North.
TA-backed TCNS files for India IPO
Indian women’s apparel retailer TCNS Clothing has filed for an IPO that will provide a partial exit for private equity investor TA Associates.
TA Associates completes exit from Australia's SpeedCast
TA Associates has made a full exit from SpeedCast, the satellite telecommunications provider it acquired in 2012 and listed in Australia two years later.
Thoma Bravo to buy Australian software player Nintex
Nintex, a workflow management software provider founded in Australia but now with a global footprint, has agreed to sell a majority stake to US-based middle market GP Thoma Bravo.
TA to buy stake in New Zealand's Fisher Funds
TA Associates will take a minority stake in Fisher Funds, New Zealand’s fifth-largest fund manager, following a move by The TSB Community Trust to assume full ownership of the business.
TA buys stake in India's Ideal Cures
TA Associates has invested in Indian pharmaceutical product supplier Ideal Cures. Neither the size of the commitment nor the size of the GP's stake in the company were disclosed.
TA backs India drug ingredients manufacturer
TA Associates has invested INR1.72 billion ($25.5 million) in listed Indian drug ingredients manufacturer Shilpa Medicare.
Timeliness the key to value-add – AVCJ Forum
PE investors must focus on speed and forward planning when implementing strategies across team building, operational improvements and crisis management, industry participants told the AVCJ Forum in Hong Kong.
Baring Asia assumes control of fashion label Cath Kidston
Baring Private Equity Asia has acquired TA Associates’ remaining stake in Cath Kidston, taking control of the UK lifestyle retailer.
TA backs MBO of Goldman's Australia equities, fixed income unit
Mid-market private equity firm TA Associates is supporting a management buyout of Goldman Sachs Asset Management’s (GSAM) Australian equities and fixed income business.
TA Associates invests $140m in India's TCNS Clothing
TA Associates has contributed to a $140 million round for Indian women’s apparel retailer TCNS Clothing.
Asia more attractive due to Western dysfunction - AVCJ Forum
The Asia opportunity for private equity has become all the more compelling for the political uncertainty blighting Western markets, investors told the AVCJ USA Forum.
Reputational due diligence: No stone unturned
Thorough reputational due diligence can find both potential deal-breakers and opportunities for improvement. Are PE firms taking it to the necessary depth in emerging markets like India?
TA promotes India, Asia heads
TA Associates has promoted Naveen Wadhera, its London-based Asia co-head, to managing director, while Dhiraj Poddar (pictured), co-head of the firm’s India business, becomes a principal.
PE-backed Dr Lal PathLabs gains on India trading debut
Shares in Indian medical diagnostics service Dr. Lal PathLabs gained more than 50% on debut following the company's INR6.3 billion ($95 million) IPO.
India's PE-backed Dr Lal PathLabs files for IPO
Indian medical diagnostic service chain Dr. Lal PathLabs has filed for an IPO, providing part exits for its PE backers WestBridge Crossover Fund and TA Associates.
PE-backed Cath Kidston buys back Japan business
Cath Kidston, the UK lifestyle retailer controlled by Baring Private Equity Asia and TA Associates, has bought back its Japan operations - its largest outside the UK - from local conglomerate TSI holdings for an undisclosed sum.
Australia's PE-backed Nintex acquires US-based Drawloop
Nintex Group, an Australian software provider backed by TA Associates, has agreed to acquire Drawloop Technologies, a US-based software platform that offers automated document services.
TA invests in India's Atria, IVFA rolls over stake
TA Associates will join India Value Fund Advisors (IVFA) to buy about 95% of Indian broadband service provider Atria Convergence Technologies (ACT). IVFA's India Value Fund III, ACT's current majority shareholder, will exit most of its stake and roll...